Active	Status	Sponsor type	Region	Phase	Filter
2 Active 2 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Liu, Qingchi
SAV, NCT05736965: A Study of Selinexor in Combination With Azacitidine and Venetoclax ( Regimen) in Treatment Naïve Participants With Acute Myeloid Leukemia	Recruiting	2	58	RoW	Selinexor, xpo1 inhibitor, Azacitidine, Venetoclax, ABT199	Shanghai Tong Ren Hospital	AML, Adult	03/25	04/27
GLB-001-02, NCT06378437: A Study of GLB-001 in Patients With Myeloid Malignancies	Recruiting	1	108	RoW	GLB-001, GLB-C183-A-2	Hangzhou GluBio Pharmaceutical Co., Ltd.	Polycythemia Vera, Essential Thrombocythemia, Myelofibrosis, Myelodysplastic Syndromes, Acute Myeloid Leukemia, Myeloid Malignancy	12/26	12/27